{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:52:28Z","timestamp":1792759948053,"version":"4.5.0"},"reference-count":40,"publisher":"Japanese Society of Veterinary Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.24-0250","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T22:11:36Z","timestamp":1739139096000},"page":"364-376","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of gelatin-epigallocatechin gallate nanoparticles with hyaluronic          acid coating for treating dry eye associated keratopathy in rats"],"prefix":"10.1292","volume":"87","author":[{"given":"Man-Ha","family":"CHAN","sequence":"first","affiliation":[{"name":"Institute of Veterinary Clinical Sciences, School of Veterinary Medicine,              National Taiwan University, Taipei, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University Veterinary              Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Li","family":"TSENG","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Materials and Tissue Engineering, College              of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsiang","family":"HUANG","sequence":"additional","affiliation":[{"name":"Graduate Institute of Molecular and Comparative Pathobiology, School of              Veterinary Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Tien","family":"LIN","sequence":"additional","affiliation":[{"name":"Institute of Veterinary Clinical Sciences, School of Veterinary Medicine,              National Taiwan University, Taipei, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University Veterinary              Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ali              Y,                Lehmussaari              K. 2006.            Industrial perspective in ocular drug delivery.              <i>Adv Drug Deliv Rev<\/i>          58: 1258\u20131268.","DOI":"10.1016\/j.addr.2006.07.022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bachu              RD, Chowdhury              P, Al-Saedi              ZHF, Karla              PK, Boddu              SHS. 2018.            Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of            anterior segment ocular diseases.            <i>Pharmaceutics<\/i>          10: 28.","DOI":"10.3390\/pharmaceutics10010028"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Barabino              S, Chen              W, Dana              MR. 2004.            Tear film and ocular surface tests in animal models of dry eye: uses and            limitations. <i>Exp Eye Res<\/i>          79: 613\u2013621.","DOI":"10.1016\/j.exer.2004.07.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Boddu              SH, Gupta              H, Patel              S. 2014.            Drug delivery to the back of the eye following topical administration: an            update on research and patenting activity. <i>Recent Pat              Drug Deliv Formul<\/i>          8: 27\u201336.","DOI":"10.2174\/1872211308666140130093301"},{"key":"5","unstructured":"5. Cavet              ME,                Harrington              KL, Vollmer              TR, Ward              KW, Zhang              JZ. 2011.            Anti-inflammatory and anti-oxidative effects of the green tea polyphenol            epigallocatechin gallate in human corneal epithelial cells.              <i>Mol Vis<\/i>          17: 533\u2013542."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chang              CY, Wang              MC, Miyagawa              T, Chen              ZY, Lin              FH, Chen              KH, Liu              GS, Tseng              CL. 2016.            Preparation of arginine-glycine-aspartic acid-modified biopolymeric            nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial            cells to inhibit corneal neovascularization. <i>Int J              Nanomedicine<\/i>          12: 279\u2013294.","DOI":"10.2147\/IJN.S114754"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chen              H, Jin              Y, Sun              L, Li              X, Nan              K, Liu              H, Zheng              Q, Wang              B. 2018.            Recent developments in ophthalmic drug delivery systems for therapy of            both anterior and posterior segment diseases. <i>Colloid              Interface Sci Commun<\/i>          24: 54\u201361.","DOI":"10.1016\/j.colcom.2018.03.008"},{"key":"8","unstructured":"8. Dursun              D, Wang              M, Monroy              D, Li              DQ, Lokeshwar              BL, Stern              ME,                Pflugfelder              SC. 2002.            A mouse model of keratoconjunctivitis sicca.              <i>Invest Ophthalmol Vis Sci<\/i>          43: 632\u2013638."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fakih              D, Zhao              Z, Nicolle              P, Reboussin              E, Joubert              F, Luzu              J, Labb\u00e9              A, Rost\u00e8ne              W, Baudouin              C, M\u00e9lik                Parsadaniantz              S, R\u00e9aux-Le                Goazigo              A. 2019.            Chronic dry eye induced corneal hypersensitivity, neuroinflammatory            responses, and synaptic plasticity in the mouse trigeminal brainstem.              <i>J Neuroinflammation<\/i>          16: 268.","DOI":"10.1186\/s12974-019-1656-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gaudana              R, Ananthula              HK, Parenky              A, Mitra              AK. 2010.            Ocular drug delivery. <i>AAPS            J<\/i>          12: 348\u2013360.","DOI":"10.1208\/s12248-010-9183-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. G\u00f6k\u00e7e              EH, Sandri              G, E\u011frilmez              S, Bonferoni              MC, G\u00fcneri              T, Caramella              C. 2009.            Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in            vivo drug release in rabbit eyes. <i>Curr Eye            Res<\/i>          34: 996\u20131003.","DOI":"10.3109\/02713680903261405"},{"key":"12","unstructured":"12. Gonzalez              GG, Garcia de la                Rubia              P, Gallar              J, Belmonte              C. 1993.            Reduction of capsaicin-induced ocular pain and neurogenic inflammation by            calcium antagonists. <i>Invest Ophthalmol Vis            Sci<\/i>          34: 3329\u20133335."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Guillaumie              F, Furrer              P,                Felt-Baeyens              O,                Fuhlendorff              BL, Nymand              S, Westh              P, Gurny              R,                Schwach-Abdellaoui              K. 2010.            Comparative studies of various hyaluronic acids produced by microbial            fermentation for potential topical ophthalmic applications.              <i>J Biomed Mater Res A<\/i>          92: 1421\u20131430.","DOI":"10.1002\/jbm.a.32481"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hagigit              T, Abdulrazik              M, Valamanesh              F,                Behar-Cohen              F, Benita              S. 2012.            Ocular antisense oligonucleotide delivery by cationic nanoemulsion for            improved treatment of ocular neovascularization: an in-vivo study in rats and            mice. <i>J Control Release<\/i>          160: 225\u2013231.","DOI":"10.1016\/j.jconrel.2011.11.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Haider              AS, Grabarek              J, Eng              B, Pedraza              P, Ferreri              NR, Balazs              EA,                Darzynkiewicz              Z. 2003.            In vitro model of \u201cwound healing\u201d analyzed by laser scanning cytometry:            accelerated healing of epithelial cell monolayers in the presence of            hyaluronate. <i>Cytometry A<\/i>          53: 1\u20138.","DOI":"10.1002\/cyto.a.10032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hathout              RM, Omran              MK. 2016.            Gelatin-based particulate systems in ocular drug          delivery. <i>Pharm Dev Technol<\/i>          21: 379\u2013386.","DOI":"10.3109\/10837450.2014.999786"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Huang              HY, Wang              MC, Chen              ZY, Chiu              WY, Chen              KH, Lin              IC, Yang              WV, Wu              CC, Tseng              CL. 2018.            Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid            decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory            relief. <i>Int J Nanomedicine<\/i>          13: 7251\u20137273.","DOI":"10.2147\/IJN.S173198"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iester              M, Orsoni              GJ, Gamba              G, Taffara              M, Mangiafico              P, Giuffrida              S, Rolando              M. 2000.            Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid            drops in keratoconjunctivitis sicca. <i>Eye            (Lond)<\/i>          14: 892\u2013898.","DOI":"10.1038\/eye.2000.244"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kaswan              R, Pappas              C, Wall              K, Hirsh              SG. 1998. Survey          of canine tear deficiency in veterinary practice. pp. 931\u2013939. In: Lacrimal Gland, Tear          Film, and Dry Eye Syndromes 2, Springer, Boston.","DOI":"10.1007\/978-1-4615-5359-5_132"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim              CS, Jo              K, Lee              IS, Kim              J. 2016.            Topical application of apricot kernel extract improves dry eye symptoms            in a unilateral exorbital lacrimal gland excision mouse.              <i>Nutrients<\/i>          8: 750.","DOI":"10.3390\/nu8110750"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kim              DW, Lee              SH, Ku              SK, Lee              JE, Cha              HJ, Youn              JK, Kwon              HY, Park              JH, Park              EY, Cho              SW, Han              KH, Park              J, Eum              WS, Choi              SY. 2015.            The effects of PEP-1-FK506BP on dry eye disease in a rat            model. <i>BMB Rep<\/i>          48: 153\u2013158.","DOI":"10.5483\/BMBRep.2015.48.3.123"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lee              HS, Chauhan              SK, Okanobo              A, Nallasamy              N, Dana              R. 2011.            Therapeutic efficacy of topical epigallocatechin gallate in murine dry            eye. <i>Cornea<\/i>          30: 1465\u20131472.","DOI":"10.1097\/ICO.0b013e31821c9b5a"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Liu              L, Tiffany              J, Dang              Z, Dart              JK, Watson              SL, Daniels              JT, Geerling              G. 2009.            Nourish and nurture: development of a nutrient ocular            lubricant. <i>Invest Ophthalmol Vis Sci<\/i>          50: 2932\u20132939.","DOI":"10.1167\/iovs.08-1991"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mecum              NE, Cyr              D, Malon              J, Demers              D, Cao              L, Meng              ID. 2019.            Evaluation of corneal damage after lacrimal gland excision in male and            female mice. <i>Invest Ophthalmol Vis Sci<\/i>          60: 3264\u20133274.","DOI":"10.1167\/iovs.18-26457"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mecum              NE, Demers              D, Sullivan              CE, Denis              TE, Kalliel              JR, Meng              ID. 2020.            Lacrimal gland excision in male and female mice causes ocular pain and            anxiety-like behaviors. <i>Sci Rep<\/i>          10: 17225.","DOI":"10.1038\/s41598-020-73945-w"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nelson              JD, Wright              JC. 1984.            Conjunctival goblet cell densities in ocular surface            disease. <i>Arch Ophthalmol<\/i>          102: 1049\u20131051.","DOI":"10.1001\/archopht.1984.01040030851031"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Norn              MS. 1970.            Micropunctate fluorescein vital staining of the cornea.              <i>Acta Ophthalmol (Copenh)<\/i>          48: 108\u2013118.","DOI":"10.1111\/j.1755-3768.1970.tb06578.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pflugfelder              SC, Tseng              SC, Yoshino              K, Monroy              D, Felix              C, Reis              BL. 1997.            Correlation of goblet cell density and mucosal epithelial membrane mucin            expression with rose bengal staining in patients with ocular irritation.              <i>Ophthalmology<\/i>          104: 223\u2013235.","DOI":"10.1016\/S0161-6420(97)30330-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Schaefer              K, George              MA, Abelson              MB, Garofalo              C. 1994. A          scanning electron micrographic comparison of the effects of two preservative-free          artificial tear solutions on the corneal epithelium as compared to a phosphate buffered          saline and a 0.02% benzalkonium chloride control. pp. 459\u2013464. In: Lacrimal Gland, Tear          Film, and Dry Eye Syndromes (Mathers WD ed.), Springer, Boston.","DOI":"10.1007\/978-1-4615-2417-5_79"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shimmura              S, Goto              E, Shimazaki              J, Tsubota              K. 1998.            Viscosity-dependent fluid dynamics of eyedrops on the ocular            surface. <i>Am J Ophthalmol<\/i>          125: 386\u2013388.","DOI":"10.1016\/S0002-9394(99)80151-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shinomiya              K, Ueta              M, Kinoshita              S. 2018.            A new dry eye mouse model produced by exorbital and intraorbital lacrimal            gland excision. <i>Sci Rep<\/i>          8: 1483.","DOI":"10.1038\/s41598-018-19578-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Skrzypecki              J, Tomasz              H, Karolina              C. 2019.          Variability of dry eye disease following removal of lacrimal glands in rats. pp. 109\u2013115.          In: Medical Science and Research (Pokorski M ed.), Springer, Cham.","DOI":"10.1007\/5584_2019_348"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tsai              CH, Wang              PY, Lin              IC, Huang              H, Liu              GS, Tseng              CL. 2018.            Ocular drug delivery: Role of degradable polymeric nanocarriers for            ophthalmic application. <i>Int J Mol Sci<\/i>          19: 2830.","DOI":"10.3390\/ijms19092830"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tseng              CL, Chen              KH, Su              WY, Lee              YH, Wu              CC, Lin              FH. 2013.            Cationic gelatin nanoparticles for drug delivery to the ocular surface:            in vitro and in vivo evaluation. <i>J            Nanomater<\/i>          2013: 1\u201311.","DOI":"10.1155\/2013\/238351"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Urtti              A. 2006.            Challenges and obstacles of ocular pharmacokinetics and drug            delivery. <i>Adv Drug Deliv Rev<\/i>          58: 1131\u20131135.","DOI":"10.1016\/j.addr.2006.07.027"},{"key":"36","unstructured":"36. Williams              D, Middleton              S, Fattahian              H, Moridpour              R. 2012.          Comparison of hyaluronic acid-containing topical eye drops with carbomer-based topical          ocular gel as a tear replacement in canine keratoconjunctivitis sicca: A prospective study          in twenty five dogs. p. 229. In: Vet Res Forum, Faculty of Veterinary Medicine, Urmia          University, Urmia."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Williams              DL. 2008.            Immunopathogenesis of keratoconjunctivitis sicca in the            dog. <i>Vet Clin North Am Small Anim            Pract<\/i>          38: 251\u2013268, vi.","DOI":"10.1016\/j.cvsm.2007.12.002"},{"key":"38","unstructured":"38. Wilson              G, Ren              H, Laurent              J. 1995.            Corneal epithelial fluorescein staining.              <i>J Am Optom Assoc<\/i>          66: 435\u2013441."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Yoon              KC, Ahn              KY, Choi              W, Li              Z, Choi              JS, Lee              SH, Park              SH. 2011.            Tear production and ocular surface changes in experimental dry eye after            elimination of desiccating stress. <i>Invest Ophthalmol Vis              Sci<\/i>          52: 7267\u20137273.","DOI":"10.1167\/iovs.11-7231"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. You              IC, Li              Y, Jin              R, Ahn              M, Choi              W, Yoon              KC. 2018.            Comparison of 0.1%, 0.18%, and 0.3% hyaluronic acid eye drops in the            treatment of experimental dry eye. <i>J Ocul Pharmacol              Ther<\/i>          34: 557\u2013564.","DOI":"10.1089\/jop.2018.0032"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/4\/87_24-0250\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:23:57Z","timestamp":1743827037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/4\/87_24-0250\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.24-0250","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0250"}}